Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Panel Of Former US FDA Commissioners Make Renewed Call For Independent Agency

Oct 26 2018

• By Michael Cipriano

FDA entrance sign 2016

Related Content

A Baker’s Dozen Of US FDA Efficacy Approvals Using Real World Evidence

Aug 08 2018

Guidance By Guidance, US FDA Is Reshaping The Look Of Cancer Drug Trials

Aug 30 2018

US FDA’s Plan On Right To Try: Big On Congressional Engagement, Short On Policy Details

Jun 13 2018

RMAT Designation, Gene Therapies Highlight 2017 CBER Transformation

Jan 18 2018

Drug Importation Can Be Triggered By 'Excessive' Price Increases; Now US FDA Has To Decide What That Means

Jul 20 2018

Right-To-Try Legislation Must Change Language To Narrow Spectrum Of Patients, Gottlieb Says

Oct 04 2017

Orphan Designations For Pediatric Subgroups Of Common Diseases To End

Dec 19 2017

Three Decades of FDA Commissioners

Jun 14 2006

HHS Overrules FDA On Plan B OTC, Sends Teva Back To Drawing Board

Dec 07 2011

An Independent FDA: An Idea Whose Time Is Still Coming

Jun 27 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Leadership FDA Regulation BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window